Epidermolysis Bullosa Acquisita: A Rare Autoimmune Blistering Disease in Children

Skinmed. 2022 Dec 20;20(6):460-462. eCollection 2022.

Abstract

A 7-year-old girl presented with a 2-year history of recurrent blisters on the skin and oral mucosa. The patient was otherwise healthy, and her family history was unremarkable for any dermatologic or other medical disease. Examination revealed multiple tense vesicles, milia, and atrophic scars present over the extensor surface of the extremities and erosions on the oral mucosa (Figure 1). A skin biopsy established a pauci-inflammatory subepidermal blister (Figure 2a). Direct immunofluorescence (DIF) evidenced the linear deposition of immunoglobulin G (IgG), immunoglobulin M (IgM), and κ and λ chains at the dermal-epithelial junction (DEJ). Indirect immunofluorescence (IIF), using the salt-split technique, established anti-epithelial antibodies on the dermal side (Figure 2b). An enzyme-linked immunosorbent assay (ELISA) was positive for Collagen Type VII (COL7) antibodies. A diagnosis of epidermolysis bullosa acquisita (EBA) was made, and treatment with azathioprine and deflazacort was administered for 8 months with progressive lessening of her symptomatology and complete clinical response at 2-year follow-up. (SKINmed. 2022;20:460-462).

Publication types

  • Case Reports

MeSH terms

  • Autoimmune Diseases* / pathology
  • Blister
  • Child
  • Epidermolysis Bullosa Acquisita*
  • Female
  • Humans
  • Immunoglobulin G
  • Skin / pathology

Substances

  • Immunoglobulin G